Лучшие больницы для «Ankle Arthroscopy» в Дубай, ОАЭ

The all-inclusive surgical cost for ankle arthroscopy in India ranges from approximately USD 2,500 to USD 6,000, depending on the complexity of the procedure. A straightforward diagnostic arthroscopy or synovectomy with loose-body removal sits at the lower end, while advanced cartilage restoration procedures such as Osteochondral Autograft Transfer System (OATS/mosaicplasty) or arthroscopic Broström-Gould ligament reconstruction—which require specialised implants such as suture anchors or chondral scaffolds—approach the upper range. In the UAE (Dubai or Abu Dhabi), equivalent procedures cost between USD 6,000 and USD 14,000, reflecting higher hospital overheads, implant import costs, and premium hotel-standard patient facilities. Both destinations include surgery, anaesthesia, one to two nights of hospital accommodation, standard medications, and post-operative compression supplies within the quoted package. Implant-specific costs (e.g., PEEK suture anchors, collagen scaffolds, or allograft cartilage) may be itemised separately in some hospitals; GAF Healthcare provides a fully itemised cost estimate before you confirm your booking so there are no surprises on discharge.

The minimum recommended in-country stay before an international flight is 2 weeks for simple procedures (synovectomy, impingement débridement, loose-body removal) and 3–4 weeks for more complex interventions (cartilage restoration with microfracture or OATS, arthroscopic ligament reconstruction). The primary concern for early air travel after ankle arthroscopy is deep vein thrombosis (DVT): lower-limb immobility, tourniquet use during surgery, and prolonged seated posture in a pressurised cabin are compounding risk factors. Before flying, your GAF-coordinated surgical team will perform a Caprini DVT risk assessment; patients at moderate-to-high risk are prescribed low-molecular-weight heparin (LMWH, e.g., enoxaparin 40 mg subcutaneously) for the flight and are mandated to wear below-knee graduated compression stockings (18–23 mmHg). In-flight, hourly ankle pump exercises are advised. Short-haul flights under 4 hours may be cleared at 2 weeks with these precautions in place; long-haul flights (>4 hours, particularly relevant for patients returning to Europe, North America, or Australia) are typically cleared at 3–4 weeks post-operatively. The final fit-to-fly clearance is provided in writing by the operating surgeon based on your wound status, swelling, and DVT risk score at the time of your 2-week follow-up appointment.

The overall clinical success rate of ankle arthroscopy is 85–95%, though outcomes vary meaningfully by the specific pathology being treated. For anterior ankle impingement syndrome (bony or soft-tissue), published series report good-to-excellent outcomes in 88–96% of patients at 2-year follow-up, with significant improvements in AOFAS (American Orthopaedic Foot and Ankle Society) ankle-hindfoot scores. For osteochondral lesions of the talus (OLT) treated with bone marrow stimulation (microfracture), success rates of 85–90% are reported for lesions under 1.5 cm²; lesions larger than 1.5 cm² treated with microfracture alone show higher failure rates (20–30%), which is why OATS mosaicplasty or AMIC scaffold augmentation is recommended for these larger defects, yielding success rates of 87–92% at 5-year follow-up. Arthroscopic Broström-Gould reconstruction for chronic lateral ankle instability demonstrates excellent outcomes in 90–95% of patients at mid-term follow-up, with return-to-sport rates exceeding 85% in athletic populations. Key prognostic factors that influence success include patient age (younger patients with isolated lesions do best), BMI (<30 kg/m² is optimal), absence of global ankle arthritis, accurate pre-operative lesion characterisation with 3T MRI and WBCT, and adherence to the structured post-operative physiotherapy protocol. GAF Healthcare selects only JCI-accredited hospitals with high-volume ankle arthroscopy programmes—typically surgeons performing >100 ankle arthroscopy cases annually—to maximise the likelihood of achieving these benchmark success rates for its international patients.